Actively Recruiting
Dome-Only Aneurysm Coiling in Severe Aneurysmal Subarachnoid Hemorrhage
Led by University of Louisville · Updated on 2026-05-11
30
Participants Needed
1
Research Sites
42 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The DOME study is a clinical trial exploring a new treatment approach for patients who suffered a severe brain bleed due to an aneurysm.
CONDITIONS
Official Title
Dome-Only Aneurysm Coiling in Severe Aneurysmal Subarachnoid Hemorrhage
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- CT confirmed aneurysmal subarachnoid hemorrhage with an angiographically detected aneurysm
- World Federation of Neurological Sciences (WFNS) aSAH grade 3-5 aneurysm
- Legally authorized representative available and able to give consent within 72 hours after onset of aSAH or last known normal
You will not qualify if you...
- Aneurysm judged appropriate for balloon-assisted coiling
- Aneurysm bleeding from the "neck"
- Clinically judged to suffer imminent death within 24 hours
- Pregnancy or positive urine pregnancy test
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Louisville Hospital
Louisville, Kentucky, United States, 40202
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here